文献速递神经肿瘤

优化颅内肿瘤手术患者结局:神经外科不良事件与死亡降低策略的前瞻性详细研究

Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery.
PubMed 文献 · Acta Neurochir (Wien) · 2024-03-08

该前瞻性研究纳入2022年1月至2023年9月一家领先神经外科三级中心接受颅内肿瘤手术的1173例成人患者,出院时由主治医师评估术后30天内不良事件。手术相关不良事件发生率为12.7%,总体死亡率为0.8%(5例死亡),作者认为详尽记录不良事件并采取主动干预策略可显著改善患者结局。

要点

  • 1173例成人颅内肿瘤手术患者中,手术相关不良事件发生率为12.7%。
  • 最常见手术指征为脑膜瘤(31.1%)和胶质瘤(28.2%)。
  • 总体死亡率为0.8%(5例),死因包括术后大出血1例、肺栓塞2例、肿瘤进展2例。

核心结论

  • 颅内肿瘤手术本身伴随显著的不良事件风险,但本队列死亡率显著较低,提示详尽记录不良事件并采取主动干预策略可大幅改善患者结局。

研究设计与样本

  • 前瞻性研究,数据来自一家领先神经外科三级中心前瞻性维护的数据库,纳入2022年1月至2023年9月接受颅内肿瘤手术的成人患者,出院时由主治医师评估术后30天内不良事件。

主要发现

  • 共1173例患者接受手术,平均年龄57.4 ± 15.3岁,择期手术占93.4%(1095/1173),急诊手术占13.9%(163/1173)。
  • 手术相关不良事件发生率为12.7%,脑膜瘤和胶质瘤分别占手术指征的31.1%和28.2%。
  • 硬膜漏发生率为1.5%,术后出血在胶质瘤患者中尤为显著,10例发生术后出血,其中8例需再次手术。
  • 总体死亡率为0.8%(5例死亡),死因为术后大出血1例、肺栓塞2例、肿瘤进展2例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Brain tumor surgery represents a critical and high-risk area within the field of neurosurgery. Our study aims to offer a comprehensive analysis of adverse events (AEs) from a prospectively maintained database at a leading neurosurgical tertiary center, with a specific focus on different types of tumor entities. METHODS: From January 2022 to September 2023, our study focused on adult patients, who underwent surgery for intracranial tumors. Each patient in this demographic was thoroughly assessed for adverse events (AEs) by their attending physicians at discharge. An AE was defined as any event occurring within the first 30 days post-surgery. RESULTS: A total of 1173 patients with an average age of 57.4 ± 15.3 years underwent surgical procedures. The majority of these surgeries were elective, accounting for 93.4% (1095 out of 1173), while emergency surgeries constituted 13.9% (163 out of 1173). The incidence of surgery-related AEs was relatively low at 12.7%. The most common surgical indications were meningioma and glioma pathologies, representing 31.1% and 28.2% of cases, respectively. Dural leaks occurred in 1.5% of the cases. Postoperative hemorrhage was a significant complication, especially among glioma patients, with ten experiencing postoperative hemorrhage and eight requiring revision surgery. The overall mortality rate stood at 0.8%, corresponding to five patient deaths. Causes of death included massive postoperative bleeding in one patient, pulmonary embolism in two patients, and tumor progression in two others. CONCLUSIONS: Surgical interventions for intracranial neoplasms are inherently associated with a significant risk of adverse events. However, our study's findings reveal a notably low mortality rate within our patient cohort. This suggests that thorough documentation of AEs, coupled with proactive intervention strategies in neurosurgical practices, can substantially enhance patient outcomes.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Lenga P, Kleineidam H, Unterberg A, et al. Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery. Acta Neurochir (Wien). 2024. PMID: 38457057. doi:10.1007/s00701-024-06008-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。